LEADER 00966nam  2200289   450 
001 9910713980603321
005 20200930142644.0
035   $a(CKB)5470000002505854
035   $a(OCoLC)1198236875
035   $a(EXLCZ)995470000002505854
100   $a20200930d2020      ua             0
101 0 $aeng
135   $aur|||||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 10$aAudit of the Drug Enforcement Administration's prescription drug Take Back activities
210  1$a[Washington, D.C.] :$cOffice of the Inspector General, Department of Justice,$d2020.
215   $a1 online resource (i, 33 pages) $ccolor illustrations
225 1 $aAudit Division ;$v20-114
300   $a"September 2020."
801  0$bGPO
801  1$bGPO
906   $aBOOK
912   $a9910713980603321
996   $aAudit of the Drug Enforcement Administration's prescription drug Take Back activities$93290898
997   $aUNINA